Synthon IP, Inc. v. Pfizer, Inc.’s Empirical Analysis
2006
Citation profile
1
cited by 1 later decisions
January 2007
most recently cited
Relationships
Relies on MARKMAN Et Al. v. WESTVIEW INSTRUMENTS, INC., Et Al. · Biogen, Inc. v. Berlex Laboratories, Inc. · 446 F. Supp. 2d 497 - Synthon IP, Inc. v. Pfizer Inc.
Most-quoted passages
The sentences later courts lift from this opinion, ranked by how many decisions quote each — the parts of the opinion doing the work. These counts are smaller than the citation total above because most of the 1 citing decisions cite the case generally; a passage count includes only decisions quoting that exact language verbatim.
“the formed intermediate... is reacted with methyl-3-aminocrotonate” to form an additional compound — the compound of formula (2)— elsewhere referred to as the”
1 later decision quote this exact passage · from the majority
How this case has been treated — in progress
Whether each later court followed, distinguished, criticized, or overruled this decision. The treatment classification (task #35) runs highest-cited cases first and lights up here as it reaches this one.